Dykgraaf R, Schalekamp Timmermans S, Adank M, van den Berg S, van de Lang Born B, Korevaar T, et al. Reference ranges of anti-Müllerian hormone and interaction with placental biomarkers in early pregnancy: the Generation R Study, a population-based prospective cohort study. Endocr Connect. 2023;12: pubmed publisher

Moolhuijsen L, Louwers Y, Laven J, Visser J. Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2022;107:e3714-e3722 pubmed publisher

Moolhuijsen L, Louwers Y, McLuskey A, Broer L, Uitterlinden A, Verdiesen R, et al. Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients. Hum Reprod. 2022;37:1544-1556 pubmed publisher

Karlamangla A, Shieh A, Greendale G, Yu E, Burnett Bowie S, Sluss P, et al. Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition. J Bone Miner Res. 2022;37:1224-1232 pubmed publisher

Anderson R, Cameron D, Clatot F, Demeestere I, Lambertini M, Nelson S, et al. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Hum Reprod Update. 2022;28:417-434 pubmed publisher

Bell R, Islam R, Skiba M, Herbert D, Martinez Garcia A, Davis S. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study. Hum Reprod. 2021;37:109-118 pubmed publisher

Ramezani Tehrani F, Sheidaei A, Firouzi F, Tohidi M, Azizi F, Behboudi Gandevani S. Does the Anti-Mullerian Hormone Decline Rate Improve the Prediction of Age at Menopause?. Front Endocrinol (Lausanne). 2021;12:727229 pubmed publisher

Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, et al. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update. Innovation (Camb). 2021;2:100091 pubmed publisher

Punchoo R, Bhoora S. Variation in the Measurement of Anti-Müllerian Hormone - What Are the Laboratory Issues?. Front Endocrinol (Lausanne). 2021;12:719029 pubmed publisher

Clendenen T, Ge W, Koenig K, Afanasyeva Y, Agnoli C, Bertone Johnson E, et al. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women. J Clin Endocrinol Metab. 2021;106:e4542-e4553 pubmed publisher

Robertson D, Lee C, Baerwald A. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age. Endocrinol Diabetes Metab. 2021;4:e00172 pubmed publisher

Mamsen L, B xf8 tkj xe6 r J, Kristensen S, Pors S, Jeppesen J, Kumar A, et al. High Variability of Molecular Isoforms of AMH in Follicular Fluid and Granulosa Cells From Human Small Antral Follicles. Front Endocrinol (Lausanne). 2021;12:617523 pubmed publisher

Caanen M, Peters H, van de Ven P, J xfc ttner A, Laven J, van Hooff M, et al. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021;106:e1084-e1095 pubmed publisher

Verdiesen R, Onland Moret N, van Gils C, Stellato R, Spijkerman A, Picavet H, et al. Anti-Müllerian hormone levels and risk of type 2 diabetes in women. Diabetologia. 2021;64:375-384 pubmed publisher

Verdiesen R, van der Schouw Y, van Gils C, Verschuren W, Broekmans F, Borges M, et al. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. medRxiv. 2020;: pubmed publisher

Anderson R, Su H. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer. Front Endocrinol (Lausanne). 2020;11:574263 pubmed publisher

Brouwer J, Dolhain R, Hazes J, Erler N, Visser J, Laven J. Decline of ovarian function in patients with rheumatoid arthritis: serum anti-Müllerian hormone levels in a longitudinal cohort. RMD Open. 2020;6: pubmed publisher

Golenbock S, Wise L, Lambert Messerlian G, Eklund E, Harlow B. Association between a history of depression and anti-müllerian hormone among late-reproductive aged women: the Harvard study of moods and cycles. Womens Midlife Health. 2020;6:9 pubmed publisher

Ferguson J, Hockley J, Rigsby P, Burns C. Establishment of a WHO Reference Reagent for anti-Mullerian hormone. Reprod Biol Endocrinol. 2020;18:86 pubmed publisher

Moolhuijsen L, Visser J. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020;105:3361-73 pubmed publisher

Oktay K, Bedoschi G, Goldfarb S, Taylan E, Titus S, Palomaki G, et al. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency. Fertil Steril. 2020;113:1251-1260.e1 pubmed publisher

Cordeiro Mitchell C, McGuinness B, Fine E, Kearns W, Christianson M, Segars J, et al. Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis. J Assist Reprod Genet. 2020;37:1037-1055 pubmed publisher

Shankara Narayana N, Yu C, Savkovic S, Desai R, Fennell C, Turner L, et al. Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men. J Clin Endocrinol Metab. 2020;105: pubmed publisher

Steiner A. AMH as a Predictor of the Final Menstrual Period. J Clin Endocrinol Metab. 2020;105: pubmed publisher

Finkelstein J, Lee H, Karlamangla A, Neer R, Sluss P, Burnett Bowie S, et al. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020;105: pubmed publisher

DiPrisco B, Kumar A, Kalra B, Savjani G, Michael Z, Farr O, et al. GLYCOSYLATED FIBRONECTIN AND INHIBIN ARE LOWER AND ANTI-MÜLLERIAN HORMONE IS HIGHER IN UMBILICAL CORD BLOOD WHEN MOTHERS HAVE PREECLAMPSIA. Endocr Pract. 2020;26:318-327 pubmed publisher

Brouwer J, Dolhain R, Hazes J, Visser J, Laven J. Reduced Ovarian Function in Female Rheumatoid Arthritis Patients Trying to Conceive. ACR Open Rheumatol. 2019;1:327-335 pubmed publisher

Toribio M, Neilan T, Awadalla M, Stone L, Rokicki A, Rivard C, et al. Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences. J Clin Endocrinol Metab. 2019;104:6090-6100 pubmed publisher

Kristensen S, Kumar A, Kalra B, Pors S, B xf8 tkj xe6 r J, Mamsen L, et al. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019;104:6371-6384 pubmed publisher

de Kat A, van der Schouw Y, Eijkemans M, Broer S, Verschuren W, Broekmans F. Can Menopause Prediction Be Improved With Multiple AMH Measurements? Results From the Prospective Doetinchem Cohort Study. J Clin Endocrinol Metab. 2019;104:5024-5031 pubmed publisher

Clendenen T, Ge W, Koenig K, Afanasyeva Y, Agnoli C, Brinton L, et al. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model. Breast Cancer Res. 2019;21:42 pubmed publisher

Ruth K, Soares A, Borges M, Eliassen A, Hankinson S, Jones M, et al. Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan. Hum Mol Genet. 2019;28:1392-1401 pubmed publisher

Upson K, Chin H, Marsh E, Baird D. Intrauterine, Infant, and Childhood Factors and Ovarian Reserve in Young African American Women. J Womens Health (Larchmt). 2019;28:1711-1720 pubmed publisher

Grynnerup A, Løssl K, Pilsgaard F, Lunding S, Storgaard M, Bogstad J, et al. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study. Reprod Biol Endocrinol. 2019;17:11 pubmed publisher

Freeman J, Whitcomb B, Roy A, Bertone Johnson E, Reich N, Healy A. A pilot longitudinal study of anti-Müllerian hormone levels throughout gestation in low risk pregnancy. Health Sci Rep. 2018;1:e53 pubmed publisher

Cameron K, Sammel M, Prewitt M, Gracia C. Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan. J Clin Endocrinol Metab. 2019;104:1813-1822 pubmed publisher

Bungum L, Tagevi J, Jokubkiene L, Bungum M, Giwercman A, Macklon N, et al. The Impact of the Biological Variability or Assay Performance on AMH Measurements: A Prospective Cohort Study With AMH Tested on Three Analytical Assay-Platforms. Front Endocrinol (Lausanne). 2018;9:603 pubmed publisher

Anderson C, Mark Park Y, Stanczyk F, Sandler D, Nichols H. Dietary factors and serum antimüllerian hormone concentrations in late premenopausal women. Fertil Steril. 2018;110:1145-1153 pubmed publisher

Purdue Smithe A, Whitcomb B, Manson J, Hankinson S, Troy L, Rosner B, et al. Vitamin D Status Is Not Associated with Risk of Early Menopause. J Nutr. 2018;148:1445-1452 pubmed publisher

Whitcomb B, Purdue Smithe A, Hankinson S, Manson J, Rosner B, Bertone Johnson E. Menstrual Cycle Characteristics in Adolescence and Early Adulthood Are Associated With Risk of Early Natural Menopause. J Clin Endocrinol Metab. 2018;103:3909-3918 pubmed publisher

Bertone Johnson E, Manson J, Purdue Smithe A, Hankinson S, Rosner B, Whitcomb B. A prospective study of inflammatory biomarker levels and risk of early menopause. Menopause. 2019;26:32-38 pubmed publisher

Bertone Johnson E, Manson J, Purdue Smithe A, Steiner A, Eliassen A, Hankinson S, et al. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study. Hum Reprod. 2018;33:1175-1182 pubmed publisher

Decanter C, Cloquet M, Dassonneville A, D Orazio E, Mailliez A, Pigny P. Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy. Reprod Biomed Online. 2018;36:711-718 pubmed publisher

Pilsgaard F, Grynnerup A, Løssl K, Bungum L, Pinborg A. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling. Acta Obstet Gynecol Scand. 2018;97:1105-1113 pubmed publisher

Shandley L, Fothergill A, Spencer J, Mertens A, Cottrell H, Howards P. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertil Steril. 2018;109:516-525.e1 pubmed publisher

Bertrand K, Eliassen A, Hankinson S, Rosner B, Tamimi R. Circulating Hormones and Mammographic Density in Premenopausal Women. Horm Cancer. 2018;9:117-127 pubmed publisher

Ge W, Clendenen T, Afanasyeva Y, Koenig K, Agnoli C, Brinton L, et al. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer. 2018;142:2215-2226 pubmed publisher

Graves J, Henry R, Cree B, Lambert Messerlian G, Greenblatt R, Waubant E, et al. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2018;90:e254-e260 pubmed publisher

Iwase A, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F. Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?. Reprod Med Biol. 2016;15:127-136 pubmed publisher

Kopp D, Wilkinson J, Bengtson A, Chipungu E, Pope R, Moyo M, et al. Fertility outcomes following obstetric fistula repair: a prospective cohort study. Reprod Health. 2017;14:159 pubmed publisher

McLennan I, Koishi K, Batchelor N, Pankhurst M. Mice with either diminished or elevated levels of anti-Müllerian hormone (AMH) have decreased litter sizes. Biol Reprod. 2017;: pubmed publisher

Jung S, Allen N, Arslan A, Baglietto L, Barricarte A, Brinton L, et al. Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer. 2018;142:262-270 pubmed publisher

Johnson L, Sammel M, Domchek S, Schanne A, Prewitt M, Gracia C. Antimüllerian hormone levels are lower in BRCA2 mutation carriers. Fertil Steril. 2017;107:1256-1265.e6 pubmed publisher

Jung S, Allen N, Arslan A, Baglietto L, Brinton L, Egleston B, et al. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertil Steril. 2017;107:1012-1022.e2 pubmed publisher

Saito A, Iwase A, Nakamura T, Osuka S, Bayasula -, Murase T, et al. Involvement of mesosalpinx in endometrioma is a possible risk factor for decrease of ovarian reserve after cystectomy: a retrospective cohort study. Reprod Biol Endocrinol. 2016;14:72 pubmed

de Kat A, van der Schouw Y, Eijkemans M, Herber Gast G, Visser J, Verschuren W, et al. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. BMC Med. 2016;14:151 pubmed

Hawkins Bressler L, Bernardi L, De Chavez P, Baird D, Carnethon M, Marsh E. Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women. Am J Obstet Gynecol. 2016;215:758.e1-758.e9 pubmed publisher

Meczekalski B, Czyzyk A, Kunicki M, Podfigurna Stopa A, Plociennik L, Jakiel G, et al. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Invest. 2016;39:1259-1265 pubmed

White A, Sandler D, D Aloisio A, Stanczyk F, Whitworth K, Baird D, et al. Antimüllerian hormone in relation to tobacco and marijuana use and sources of indoor heating/cooking. Fertil Steril. 2016;106:723-30 pubmed publisher

Bertrand K, Baer H, Orav E, Klifa C, Kumar A, Hylton N, et al. Early Life Body Fatness, Serum Anti-Müllerian Hormone, and Breast Density in Young Adult Women. Cancer Epidemiol Biomarkers Prev. 2016;25:1151-7 pubmed publisher

Marsh E, Bernardi L, Steinberg M, De Chavez P, Visser J, Carnethon M, et al. Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old). Fertil Steril. 2016;106:443-450.e2 pubmed publisher

Mamsen L, Munthe Fog L, Petersen T, Jeppesen J, M xf8 llg xe5 rd K, Gr xf8 ndahl M, et al. Reply: Methodological considerations in measuring different AMH splice forms using ELISA: validity of proAMH ELISA. Mol Hum Reprod. 2016;22:374-5 pubmed publisher

Pankhurst M, Leathart B, Batchelor N, McLennan I. The Anti-Müllerian Hormone Precursor (proAMH) Is Not Converted to the Receptor-Competent Form (AMHN,C) in the Circulating Blood of Mice. Endocrinology. 2016;157:1622-9 pubmed publisher

Dean A, van den Driesche S, Wang Y, McKinnell C, Macpherson S, Eddie S, et al. Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences. Sci Rep. 2016;6:19789 pubmed publisher

Iwase A, Osuka S, Nakamura T, Kato N, Takikawa S, Goto M, et al. Usefulness of the Ultrasensitive Anti-Müllerian Hormone Assay for Predicting True Ovarian Reserve. Reprod Sci. 2016;23:756-60 pubmed publisher

Cui L, Qin Y, Gao X, Lu J, Geng L, Ding L, et al. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Fertil Steril. 2016;105:481-5.e1 pubmed publisher

Burks H, Ross L, Opper N, Paulson E, Stanczyk F, Chung K. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?. Fertil Steril. 2015;104:643-8 pubmed publisher

Nichols H, Baird D, Stanczyk F, Steiner A, Troester M, Whitworth K, et al. Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk. Cancer Prev Res (Phila). 2015;8:528-34 pubmed publisher

Iliodromiti S, Anderson R, Nelson S. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21:698-710 pubmed publisher

Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2015;22:519-26 pubmed publisher

Chai J, Howie A, Cameron D, Anderson R. A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer. Eur J Cancer. 2014;50:2367-74 pubmed publisher

Decanter C, Peigné M, Mailliez A, Morschhauser F, Dassonneville A, Dewailly D, et al. Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay. Fertil Steril. 2014;102:483-7 pubmed publisher

Broer S, Broekmans F, Laven J, Fauser B. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20:688-701 pubmed publisher

Robertson D, Kumar A, Kalra B, Shah S, Pruysers E, Vanden Brink H, et al. Detection of serum antimüllerian hormone in women approaching menopause using sensitive antimüllerian hormone enzyme-linked immunosorbent assays. Menopause. 2014;21:1277-86 pubmed publisher

Su H, Sammel M, Homer M, Bui K, Haunschild C, Stanczyk F. Comparability of antimüllerian hormone levels among commercially available immunoassays. Fertil Steril. 2014;101:1766-72.e1 pubmed publisher

Welsh P, Smith K, Nelson S. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Hum Reprod. 2014;29:1035-41 pubmed publisher